Figure 11.
Viability of HCT-116 cells treated with sorafenib—(SOR)- and doxorubicin—(DOX)-loaded PHB and PEGylated-PHB nanoparticles and with the solution of drugs and that of untreated cells (negative control).
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.